| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_399f43c51e40666f21a884409259b9e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20041 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbce6b55bd042ac29c72b00ef68fb20e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3cc0ad37cc019e2d0846c23298c754c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fa73b1bf293b1c9a81ff9c99ff5d684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd1a2c058536bdd97354995aa1a505f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed9c04c768b79221085bad89aa0ab02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50223c4686a66865b12c224c7c7a3486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45105d55900ac173842181b79b47eb3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29aadc843728c2cbedb8ed57f90544a5 |
| publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102005685-B1 |
| titleOfInvention |
Recombinant vector of MERS-CoV expressing fluorescence protein derived from Korean MERS-CoV, and method of preparing the same |
| abstract |
The present invention provides a full-length clone of Ms. coronavirus based on a Korean isolate, which is difficult to clone an entire body of a foreign-derived mers coronavirus, and a method for producing the same. Also provided is a fusion protein recombinant vector expressing a muller coronavirus wherein a tomato red florescence protein (RFP) gene is further inserted into a Korean isolate mers coronavirus full-length clone, and a method for producing the recombinant vector. The clone of Ms. coronavirus based on the isolate of Korea of the present invention can be utilized as a standard material for evaluating the efficacy of a therapeutic agent and a vaccine in a cell line and an animal model while maintaining the infectivity and replication ability upon restoration with a virus, And it can be utilized in the development of vaccinated vaccine stocks. |
| priorityDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |